Cargando…
Using a Modified Delphi Panel to Estimate Health Service Utilization for Patients with Advanced and Non-Advanced Systemic Light Chain Amyloidosis
PURPOSE: Patients with diagnosed with systemic light chain (AL) amyloidosis at advanced Mayo stages have greater morbidity and mortality than those diagnosed at non-advanced stages. Estimating service use by severity is difficult because Mayo stage is not available in many secondary databases. We us...
Autores principales: | Gertz, Morie, Abonour, Rafat, Gibbs, Sarah N, Finkel, Muriel, Landau, Heather, Lentzsch, Suzanne, Lin, Grace, Mahindra, Anuj, Quock, Tiffany, Rosenbaum, Cara, Rosenzweig, Michael, Sidana, Surbhi, Tuchman, Sascha A, Witteles, Ronald, Yermilov, Irina, Broder, Michael S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503521/ https://www.ncbi.nlm.nih.gov/pubmed/37719133 http://dx.doi.org/10.2147/CEOR.S412079 |
Ejemplares similares
-
Advances in the treatment of hereditary transthyretin amyloidosis: A review
por: Gertz, Morie A., et al.
Publicado: (2019) -
Role of Daratumumab in Cardiac AL Amyloidosis
por: Gertz, Morie A.
Publicado: (2022) -
Organ response in patients with AL amyloidosis treated with NEOD001, an amyloid‐directed monoclonal antibody
por: gertz, morie a., et al.
Publicado: (2016) -
Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2018
por: Gertz, Morie A.
Publicado: (2018) -
Untangling the clinical and economic burden of hospitalization for cardiac amyloidosis in the United States
por: Quock, Tiffany P, et al.
Publicado: (2019)